All In Biotech

Drug Trial Radar · NCT05003245

Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

A Phase 3 Randomized Double-masked Active Controlled Study to Compare the Efficacy and Safety of HLX04-O Administered by Intravitreal Injection with Ranibizumab in Subjects with Wet Age Related Macular Degeneration (wAMD)

Last checked: Nov 20, 2026Latest source record: Mar 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 407 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

407

Actual

Start

Nov 1, 2021

Primary completion

May 7, 2024

Study completion May 7, 2024

Sponsor

Lead sponsor
Shanghai Henlius BiotechIndustry
Sponsor type
Industry
First posted
Aug 12, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

this study will compare the efficacy and safety of HLX04-O administered by IVT with ranibizumab in patients with active CNV secondary to AMD.

Conditions

  • Age Related Macular Degeneration

Interventions

  • HLX04-O,recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injectionDrug

    0.05mL solution at a 4-week interval for intravitreal injection

  • LucentisDrug

    0.05mL solution at a 4-week interval for intravitreal injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean change of letters from baseline in best-corrected visual acuity (BCVA) at Week 48.Time frame: from baseline to week 48

Locations

41 sites in 1 country. Site status is shown where the registry gives one.

  • The first affiliated hospital of bengbu medical college

    Bengbu, Anhui, China

  • The Second Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, China

  • Beijing Tongren Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

  • Chinese PLA General Hospital

    Beijing, Beijing Municipality, China

  • Xuanwu Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

  • The First Affiliated Hospital of Third Military Medical University (Southwest Hospital)

    Chongqing, Chongqing Municipality, China

  • The Second Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China

  • The Second Hospital of Lanzhou University

    Lanzhou, Gansu, China

  • The First Affiliated Hospital of Jinan University (Guangzhou Overseas Chinese Hospital )

    Guangzhou, Guangdong, China

  • Zhujiang Hospital of Southern Medical University

    Guangzhou, Guangdong, China

  • Jieyang People's Hospital

    Jieyang, Guangdong, China

  • The First Affiliated Hospital of Guangxi Medical University

    Nanjing, Guangxi, China

  • The People's Hospital of Guangxi Zhuang Autonomous Region

    Nanning, Guangxi, China

  • Affiliated Hospital of Guizhou Medical University

    Guiyang, Guizhou, China

  • The First People's Hospital of Zunyi

    Zunyi, Guizhou, China

  • Cangzhou Central Hospital

    Cangzhou, Hebei, China

  • The First Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang, China

  • Luoyang Third People's Hospital

    Luoyang, Henan, China

  • The First Affiliated Hospital of Xinxiang Medical College

    Xinxiang, Henan, China

  • The Third Affiliated Hospital of Xinxiang Medical College

    Xinxiang, Henan, China

  • Henan Eye Hospital

    Zhengzhou, Henan, China

  • People's Hospital of Wuhan University (Hubei Provincial People's Hospital)

    Wuhan, Hubei, China

  • Tongji hospital, Tongji medical college, Huazhong University of Science and Technology

    Wuhan, Hubei, China

  • Wuhan AIER Eye Hospital

    Wuhan, Hubei, China

  • Wuhan Puren Hospital

    Wuhan, Hubei, China

  • Yichang Central People's Hospital

    Yichang, Hubei, China

  • Affiliated Eye Hospital of Nanchang University

    Nanchang, Jiangxi, China

  • the First Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, China

  • Pingxiang People's Hospital

    Pingxiang, Jiangxi, China

  • The First Hospital of Jilin University

    Jilin City, Jilin, China

  • Shenyang AIER Eye Hospital

    Shenyang, Liaoning, China

  • Ningxia Hui Autonomous Region Peoples Hospital

    Yinchuan, Ningxia, China

  • Shangdong Provincial Hospital

    Jinan, Shandong, China

  • The Affiliated Hospital of Qingdao University

    Qingdao, Shandong, China

  • Weifang Eye Hospital

    Weifang, Shandong, China

  • Shanghai General Hospital

    Shanghai, Shanghai Municipality, China

  • Shanghai Tenth People's Hospital

    Shanghai, Shanghai Municipality, China

  • Shanxi Eye Hospital

    Taiyuan, Shanxi, China

  • Tianjin Eye Hospital

    Tianjin, Tianjin Municipality, China

  • Zhejiang provincial people's hospital

    Hangzhou, Zhejiang, China

Showing 40 of 41 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.